Navigation Links
ViroPharma Launches 'HAE and Me,' A New Online Community to Unite People Living With Hereditary Angioedema
Date:3/21/2011

ritten profiles of people with HAE and physicians
  • Tips and advice from people with HAE and physicians
  • Quarterly physician spotlights
  • Monthly polls
  • Answers to frequently asked questions about HAE
  • Upcoming events

  • "Gen HAE," which was developed with input from teens and young adults living with HAE, focuses specifically on the important issues young people growing up with chronic conditions like HAE may face.  Unique to "Gen HAE," visitors can also submit questions to Dr. Miriam Kaufman, a pediatrician who has worked for 27 years with young people who have chronic conditions.  

    Information on "HAE and Me" will be regularly updated to include new information and interactive elements, potentially including an interactive map to visually link HAE patients, and a calendar of relevant events around the country.  "HAE and Me" will also expand to include targeted content for other sub-communities of people affected by HAE, such as parents or caregivers.

    About Hereditary Angioedema

    HAE is a rare, severely debilitating, life-threatening genetic disorder caused by a deficiency of C1 inhibitor, a human plasma protein. This condition is the result of a defect in the gene controlling the synthesis of C1 inhibitor. C1 inhibitor maintains the natural regulation of the contact, complement, and fibrinolytic systems, that when left unregulated, can initiate or perpetuate an attack by consuming the already low levels of endogenous C1 inhibitor in HAE patients. Patients with C1 inhibitor deficiency experience recurrent, unpredictable, debilitating, and potentially life threatening attacks of inflammation affecting the larynx, abdomen, face, extremities and urogenital tract. Patients with HAE experience approximately 20 to 100 days of incapacitation per year. There are estimated to be at least 6,500 people with HAE in the United States.

    For more information o
    '/>"/>

    SOURCE ViroPharma Incorporated
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4

    Related medicine technology :

    1. ViroPharma Announces Positive CHMP Opinion for Cinryze® (C1 Inhibitor [Human]) in European Union
    2. ViroPharma Announces Securities Repurchase Program
    3. ViroPharma to Participate in Two March Healthcare Conferences
    4. ViroPharma to Release 2010 Fourth Quarter and Full Year Financial Results on February 24, 2011
    5. ViroPharma to Participate in Several Upcoming Healthcare Investor Conferences
    6. ViroPharma Receives Complete Response Letter for Cinryze™ (C1 Esterase Inhibitor [Human]) Industrial Scale Supplement
    7. ViroPharma to Release 2010 Third Quarter Financial Results on October 27, 2010
    8. ViroPharma to Present at the Jefferies 2010 Global Healthcare Conference
    9. ViroPharma Announces Presentation of Data from Non-Toxigenic Clostridium difficile (VP20621) Phase 1 Study
    10. ViroPharma To Participate in Two September Healthcare Investor Conferences
    11. ViroPharma Announces Publication of Cinryze™ (C1 Esterase Inhibitor [Human]) Phase 3 Trial Results in Hereditary Angioedema (HAE) in the New England Journal of Medicine
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/29/2014)... Calif. , Aug. 29, 2014 Medina ... as CEO and member of the Board of Directors ... of medical device development and commercialization experience, including over ... Mr. Engelson previously served as a Partner of the ... President and CEO of two Foundry start-ups. Mr. Engelson ...
    (Date:8/29/2014)... 29, 2014 Research and Markets ... Instrument Industry Report, 2014-2017" report to their offering. ... rising proportion of reimbursement for medical expenses, the Chinese ... its scale presenting a CAGR of 19.2% during 2009-2013. ... product segments of orthopedic instruments in China ...
    (Date:8/29/2014)... , August 29, 2014 ... Seed Oil Market by Extraction type (SFE, Cold ... & Personal Care, Pharmaceutical, Food Supplements, Fragrance, & Others) ... by MarketsandMarkets, defines and segments the Amaranth Seed ... the market size in terms of value. The ...
    Breaking Medicine Technology:Medina Medical Announces Erik T. Engelson Joins as Chief Executive Officer 2China Orthopedic Instrument Industry Report, 2014-2017 2Amaranth Seed Oil Market worth $700.6 Million by 2019 2Amaranth Seed Oil Market worth $700.6 Million by 2019 3Amaranth Seed Oil Market worth $700.6 Million by 2019 4
    ... Sept. 21, 2011 Reportlinker.com announces that a ... catalogue: Generic Drugs: The ... http://www.reportlinker.com/p0619264/Generic-Drugs-The-Global-Market-Focus-on-the-Americas.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Machine_Tool_and_Equipment ... examination of the strategies employed by companies specializing ...
    ... SAN DIEGO, Sept. 20, 2011 Orexigen® Therapeutics, Inc. ... a recent meeting with senior officials in FDA,s Office ... detailing OND,s design requirements for a cardiovascular outcomes trial ... Letter (CRL) received in January 2011. Orexigen believes that ...
    Cached Medicine Technology:Generic Drugs: The Global Market: Focus on the Americas 2Generic Drugs: The Global Market: Focus on the Americas 3Generic Drugs: The Global Market: Focus on the Americas 4Generic Drugs: The Global Market: Focus on the Americas 5Generic Drugs: The Global Market: Focus on the Americas 6Generic Drugs: The Global Market: Focus on the Americas 7Generic Drugs: The Global Market: Focus on the Americas 8Generic Drugs: The Global Market: Focus on the Americas 9Generic Drugs: The Global Market: Focus on the Americas 10Orexigen and FDA Identify a Clear and Feasible Path to Approval for Contrave® 2Orexigen and FDA Identify a Clear and Feasible Path to Approval for Contrave® 3Orexigen and FDA Identify a Clear and Feasible Path to Approval for Contrave® 4Orexigen and FDA Identify a Clear and Feasible Path to Approval for Contrave® 5
    (Date:8/29/2014)... (PRWEB) August 29, 2014 As reported by ... Monitoring For Drug Abuse Trends , Outbreaks (8/20), the National ... attempt to monitor drug abuse trends by turning to social ... drug abuse trends, it is also working with the University ... National Drug Early Warning System, which will be funded by ...
    (Date:8/29/2014)... Market Research Report on Global ... professional and in-depth market survey on Global and ... the basic information of Glass microfiber including its ... explores global and China’s top manufacturers of Glass ... and market share etc. , The report further ...
    (Date:8/29/2014)... August 29, 2014 Dr. Parsa Mohebi M.D. ... of hair loss achieve great results in hair transplantation. ... Hair Transplant , an FUE method that harvests facial hair ... This method lets patients whose hair loss classification is 5 ... Transplant is a great alternative for those advanced hair loss ...
    (Date:8/29/2014)... -- Astronauts may be at heightened risk of ... systems, a new study suggests. That could be ... the moon and Mars undertaken in the future, because ... be dangerous, NASA researchers say. They found that ... International Space Station crew members remains relatively unchanged during ...
    (Date:8/29/2014)... 2014 Healthpointe Medical Group, one ... medical center from LAXMed. The medical center is less than ... miles west of the 405 freeway. , The LAX ... new LAX center is located at: 8610 S. Sepulveda Blvd., ... Healthpointe LAX office will provide the same comprehensive ...
    Breaking Medicine News(10 mins):Health News:Social Media Proves to Be Helpful in Fighting Drug Abuse 2Health News:Social Media Proves to Be Helpful in Fighting Drug Abuse 3Health News:Global and Chinese Glass Microfiber Industry Forecasts to 2019 in New Research Report Available at ReportsnReports.com 2Health News:Global and Chinese Glass Microfiber Industry Forecasts to 2019 in New Research Report Available at ReportsnReports.com 3Health News:Global and Chinese Glass Microfiber Industry Forecasts to 2019 in New Research Report Available at ReportsnReports.com 4Health News:Advanced Hair Loss Patients Can Now Qualify for Hair Transplants Using Facial Donor Hair 2Health News:Spaceflight Might Weaken Astronauts' Immune Systems 2Health News:Healthpointe Obtains a New Medical Clinic in the LAX Area 2
    ... Mayo Clinic review of patients responses to a drug ... general surgery questions a U.S. Food and Drug Administration ... appears in the current issue of the journal Anesthesiology. ... 2001 over concerns that the drug contributed to potentially ...
    ... This Decade ... OAKLAND, Calif., Sept. 28 Registered nurses at up to 16,Northern ... a major strike in October that could involve up to 5,500 ... Group in Yuba City and Marysville. Strike notices are being ...
    ... Center at Jefferson in Philadelphia have discovered new molecular ... breast cancer. They have found that prolactin, a pituitary ... initiates a new signaling pathway that may regulate the ... The work, which appears this month in the journal ...
    ... of William V. Corr, Executive Director, Campaign for,Tobacco-Free ... is a,statement of William V. Corr, Executive Director, ... will fall further behind in protecting,workers and the ... as two,more states - neighboring Maryland and Minnesota ...
    ... Insurance,Holdings, Inc. ("EIHI") (Nasdaq: EIHI ) announced ... Insurance Group ("EAIG") in the new position of,Regional ... an,indirect wholly-owned subsidiary of EIHI. EAIG entered ... licenses to underwrite in North Carolina, Virginia,Georgia and ...
    ... Cross,announces it has signed new three-year contracts with ... part of Catholic Health East health care,system, effective ... includes Mercy Fitzgerald Hospital, Mercy,Hospital of Philadelphia, Mercy ... Hospital, as well as Mercy Home Health and ...
    Cached Medicine News:Health News:Mayo Clinic study finds FDA warning against antinausea drug droperidol unnecessary 2Health News:RNs to Announce October Strike of 5,500 Nurses 2Health News:Jefferson researchers uncover new evidence of prolactin's possible role in breast cancer 2Health News:Maryland, Minnesota Go Smoke-free Oct. 1 - Pennsylvania Overdue in Following Suit 2Health News:Eastern Alliance Insurance Group Appoints Cox Regional Marketing Director for Southeast 2Health News:Independence Blue Cross Finalizes New Multi-Year Agreements with Mercy Health System and St. Mary Medical Center 2Health News:Independence Blue Cross Finalizes New Multi-Year Agreements with Mercy Health System and St. Mary Medical Center 3
    The ACCU-Beam® line of Surgical Microscope Accessories includes digital camera adaptors, beam splitters, objective lenses, fiber optic cables, and fiberoptic retrofits....
    The ACCU-Beam® line of Surgical Microscope Accessories includes digital camera adaptors, beam splitters, objective lenses, fiber optic cables, and fiberoptic retrofits....
    The ACCU-Beam® line of Surgical Microscope Accessories includes digital camera adaptors, beam splitters, objective lenses, fiber optic cables, and fiberoptic retrofits....
    The ACCU-Beam® line of Surgical Microscope Accessories includes digital camera adaptors, beam splitters, objective lenses, fiber optic cables, and fiberoptic retrofits....
    Medicine Products: